Park Avenue Securities’s Vericel VCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding VCEL
Park Avenue Securities's VCEL Position: Q3 2026 in Review
Park Avenue Securities reduced its Vericel (VCEL) stake by 2.9% in Q3 2026, selling an estimated $7.32K and leaving 5,751 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1659.
Park Avenue Securities first reported a position in VCEL in Q1 2024 and has held it in 6 quarters since. The position peaked at $280K in Q4 2024. 320 funds tracked by Wall St. Rank hold VCEL as of Q3 2026.
- Park Avenue Securities held 5,751 shares of Vericel worth $231K as of Q3 2026.
- Park Avenue Securities sold 169 Vericel shares in Q3 2026, an estimated $7.32K.
- Vericel made up ﹤0.01% of Park Avenue Securities's portfolio in Q3 2026, its #1659 holding.
- Park Avenue Securities first reported a position in Vericel in Q1 2024 and has held it in 6 quarters since.
- Park Avenue Securities's Vericel position peaked at $280K in Q4 2024.
- 320 funds tracked by Wall St. Rank held Vericel as of Q3 2026.
Based on Park Avenue Securities's 13F filing for Q3 2026, filed 26 Oct 2026.